Other indications which physicians said could be the future of GLP-a research include nonalcoholic fatty liver disease (37 percent), osteoarthritis (30 percent), and chemical dependency (30 percent)
L-carnitine showed no significant effect on waist circumference
Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming
Not only would the way of taking the drug be easier for most, but the company also said the drug would be cheaper to manufacture
Bishehsari F, Magno E, Swanson G, Desai V, Voigt RM, Forsyth CB, et al
Initially approval was for an injectable version, but in September 2019 an oral form, called Rybelsus, was approved in the US and then in the European Union in April 2020